• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PCPE-1,一种来源于棕色脂肪组织的细胞因子,可促进肥胖诱导的肝纤维化。

PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis.

机构信息

Department of Cardiovascular Aging, National Cerebral and Cardiovascular Center Research Institute, Osaka, 564-8565, Japan.

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan.

出版信息

EMBO J. 2024 Nov;43(21):4846-4869. doi: 10.1038/s44318-024-00196-0. Epub 2024 Aug 19.

DOI:10.1038/s44318-024-00196-0
PMID:39160276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11535236/
Abstract

Metabolic dysfunction-associated steatohepatitis (MASH, previously termed non-alcoholic steatohepatitis (NASH)), is a major complication of obesity that promotes fatty liver disease. MASH is characterized by progressive tissue fibrosis and sterile liver inflammation that can lead to liver cirrhosis, cancer, and death. The molecular mechanisms of fibrosis in MASH and its systemic control remain poorly understood. Here, we identified the secreted-type pro-fibrotic protein, procollagen C-endopeptidase enhancer-1 (PCPE-1), as a brown adipose tissue (BAT)-derived adipokine that promotes liver fibrosis in a murine obesity-induced MASH model. BAT-specific or systemic PCPE-1 depletion in mice ameliorated liver fibrosis, whereas, PCPE-1 gain of function in BAT enhanced hepatic fibrosis. High-calorie diet-induced ER stress increased PCPE-1 production in BAT through the activation of IRE-1/JNK/c-Fos/c-Jun signaling. Circulating PCPE-1 levels are increased in the plasma of MASH patients, suggesting a therapeutic possibility. In sum, our results uncover PCPE-1 as a novel systemic control factor of liver fibrosis.

摘要

代谢相关脂肪性肝炎(MASH,以前称为非酒精性脂肪性肝炎(NASH))是肥胖的主要并发症,可促进脂肪肝疾病。MASH 的特征是进行性组织纤维化和无菌性肝炎症,可导致肝硬化、癌症和死亡。MASH 纤维化的分子机制及其系统控制仍知之甚少。在这里,我们鉴定了分泌型促纤维化蛋白前胶原 C 端肽酶增强子 1(PCPE-1),作为一种棕色脂肪组织(BAT)衍生的脂肪因子,可促进肥胖诱导的 MASH 模型中的肝纤维化。在小鼠中,BAT 特异性或全身性 PCPE-1 耗竭可改善肝纤维化,而 BAT 中 PCPE-1 的功能获得则增强肝纤维化。高卡路里饮食诱导的内质网应激通过激活 IRE-1/JNK/c-Fos/c-Jun 信号通路增加 BAT 中 PCPE-1 的产生。MASH 患者的血浆中循环 PCPE-1 水平升高,提示有治疗可能性。总之,我们的结果揭示了 PCPE-1 是肝纤维化的一种新型系统控制因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/933fba6a022a/44318_2024_196_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/bba8fea1cf18/44318_2024_196_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/d92fe21b3793/44318_2024_196_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/14740c9a8d32/44318_2024_196_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/4e33b4566431/44318_2024_196_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/e8fec25aad55/44318_2024_196_Fig5_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/5d36b9f37929/44318_2024_196_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/01af22cbfb49/44318_2024_196_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/933fba6a022a/44318_2024_196_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/bba8fea1cf18/44318_2024_196_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/d92fe21b3793/44318_2024_196_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/14740c9a8d32/44318_2024_196_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/4e33b4566431/44318_2024_196_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/e8fec25aad55/44318_2024_196_Fig5_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/5d36b9f37929/44318_2024_196_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/01af22cbfb49/44318_2024_196_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b4/11535236/933fba6a022a/44318_2024_196_Fig8_ESM.jpg

相似文献

1
PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis.PCPE-1,一种来源于棕色脂肪组织的细胞因子,可促进肥胖诱导的肝纤维化。
EMBO J. 2024 Nov;43(21):4846-4869. doi: 10.1038/s44318-024-00196-0. Epub 2024 Aug 19.
2
Procollagen C-Proteinase Enhancer-1 (PCPE-1) deficiency in mice reduces liver fibrosis but not NASH progression.小鼠中前胶原C蛋白酶增强因子-1(PCPE-1)缺乏可减轻肝纤维化,但不影响非酒精性脂肪性肝炎的进展。
PLoS One. 2022 Feb 11;17(2):e0263828. doi: 10.1371/journal.pone.0263828. eCollection 2022.
3
The evolution of steatosis and fibrosis in mice on a MASH-inducing diet and the effects of housing temperature.采用致MASH饮食的小鼠脂肪变性和纤维化的演变及饲养温度的影响
Am J Physiol Endocrinol Metab. 2025 Apr 1;328(4):E513-E523. doi: 10.1152/ajpendo.00401.2024. Epub 2025 Feb 25.
4
Egr2 drives the differentiation of Ly6C monocytes into fibrosis-promoting macrophages in metabolic dysfunction-associated steatohepatitis in mice.Egr2 驱动 Ly6C 单核细胞分化为代谢功能障碍相关脂肪性肝炎小鼠肝纤维化促进型巨噬细胞。
Commun Biol. 2024 Jun 3;7(1):681. doi: 10.1038/s42003-024-06357-5.
5
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.生长分化因子 15 可改善小鼠的非酒精性脂肪性肝炎及相关代谢紊乱。
Sci Rep. 2018 May 1;8(1):6789. doi: 10.1038/s41598-018-25098-0.
6
TJ0113 attenuates fibrosis in metabolic dysfunction-associated steatohepatitis by inducing mitophagy.TJ0113通过诱导线粒体自噬减轻代谢功能障碍相关脂肪性肝炎中的纤维化。
Int Immunopharmacol. 2025 May 27;156:114678. doi: 10.1016/j.intimp.2025.114678. Epub 2025 Apr 18.
7
Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development.肝细胞 REck 作为代谢功能障碍相关脂肪性肝炎发展的关键调节因子。
Cell Mol Gastroenterol Hepatol. 2024;18(3):101365. doi: 10.1016/j.jcmgh.2024.101365. Epub 2024 May 24.
8
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC.肥胖驱动 STAT-1 依赖性 NASH 和 STAT-3 依赖性 HCC。
Cell. 2018 Nov 15;175(5):1289-1306.e20. doi: 10.1016/j.cell.2018.09.053. Epub 2018 Oct 25.
9
Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis.植物油基生酮饮食可改善实验性代谢功能障碍相关脂肪性肝炎中的炎症和纤维化。
Front Immunol. 2025 Apr 1;16:1518687. doi: 10.3389/fimmu.2025.1518687. eCollection 2025.
10
Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.Nrg4 可促进燃料氧化和健康的脂肪细胞因子谱,改善饮食诱导的代谢紊乱。
Mol Metab. 2017 Jun 21;6(8):863-872. doi: 10.1016/j.molmet.2017.03.016. eCollection 2017 Aug.

引用本文的文献

1
Research progress of PYK2 in digestive system diseases.PYK2在消化系统疾病中的研究进展
Front Immunol. 2025 Jul 17;16:1614589. doi: 10.3389/fimmu.2025.1614589. eCollection 2025.
2
Associations between an inflammatory diet index and nonunion: a prospective study of 172,839 UK biobank participants.炎症饮食指数与骨不连之间的关联:对172,839名英国生物银行参与者的前瞻性研究。
Front Nutr. 2025 Jul 14;12:1640259. doi: 10.3389/fnut.2025.1640259. eCollection 2025.
3
Transcriptional control of brown adipocyte differentiation and function by NFIA: recent perspectives on deciphering metabolic diseases.

本文引用的文献

1
Fatty acid desaturase 2 determines the lipidomic landscape and steroidogenic function of the adrenal gland.脂肪酸去饱和酶 2 决定肾上腺的脂质组学特征和类固醇生成功能。
Sci Adv. 2023 Jul 21;9(29):eadf6710. doi: 10.1126/sciadv.adf6710.
2
Challenges and opportunities in NASH drug development.非酒精性脂肪性肝炎药物研发的挑战与机遇。
Nat Med. 2023 Mar;29(3):562-573. doi: 10.1038/s41591-023-02242-6. Epub 2023 Mar 9.
3
Isolation and Culture of Primary Fibroblasts from Neonatal Murine Hearts to Study Cardiac Fibrosis.从新生小鼠心脏中分离和培养原代成纤维细胞以研究心脏纤维化
NFIA对棕色脂肪细胞分化和功能的转录调控:解读代谢疾病的最新观点
J Biochem. 2025 Sep 3;178(3):147-159. doi: 10.1093/jb/mvaf038.
4
Functional genomics reveals adipose-kidney crosstalk as a contributor to kidney fibrosis via the OSM-OSMR pathway.功能基因组学揭示了脂肪-肾脏间的串扰通过OSM-OSMR途径促进肾脏纤维化。
Funct Integr Genomics. 2025 Jun 2;25(1):114. doi: 10.1007/s10142-025-01624-y.
5
BATokines in metabolic liver disease: good cops or bad cops?代谢性肝病中的褐色脂肪组织细胞因子:是“好警察”还是“坏警察”?
EMBO J. 2024 Nov;43(21):4807-4809. doi: 10.1038/s44318-024-00239-6. Epub 2024 Sep 25.
Bio Protoc. 2023 Feb 20;13(4):e4616. doi: 10.21769/BioProtoc.4616.
4
Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice.棕色脂肪组织衍生的 Nrg4 可减轻雄性小鼠的血管内皮炎症和动脉粥样硬化。
Nat Metab. 2022 Nov;4(11):1573-1590. doi: 10.1038/s42255-022-00671-0. Epub 2022 Nov 18.
5
The human batokine EPDR1 regulates β-cell metabolism and function.人类 Batokine EPDR1 调节β细胞代谢和功能。
Mol Metab. 2022 Dec;66:101629. doi: 10.1016/j.molmet.2022.101629. Epub 2022 Nov 5.
6
High-fat diet-induced obesity augments the deleterious effects of estrogen deficiency on bone: Evidence from ovariectomized mice.高脂肪饮食诱导的肥胖会加剧雌激素缺乏对骨骼的有害影响:来自去卵巢小鼠的证据。
Aging Cell. 2022 Dec;21(12):e13726. doi: 10.1111/acel.13726. Epub 2022 Oct 10.
7
A global view of the interplay between non-alcoholic fatty liver disease and diabetes.非酒精性脂肪性肝病与糖尿病之间相互作用的全球观。
Lancet Diabetes Endocrinol. 2022 Apr;10(4):284-296. doi: 10.1016/S2213-8587(22)00003-1. Epub 2022 Feb 17.
8
Procollagen C-Proteinase Enhancer-1 (PCPE-1) deficiency in mice reduces liver fibrosis but not NASH progression.小鼠中前胶原C蛋白酶增强因子-1(PCPE-1)缺乏可减轻肝纤维化,但不影响非酒精性脂肪性肝炎的进展。
PLoS One. 2022 Feb 11;17(2):e0263828. doi: 10.1371/journal.pone.0263828. eCollection 2022.
9
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week.非酒精性脂肪性肝病患者发生心力衰竭的风险:JACC 综述专题。
J Am Coll Cardiol. 2022 Jan 18;79(2):180-191. doi: 10.1016/j.jacc.2021.11.007.
10
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的进行性肝纤维化。
Cells. 2021 Dec 2;10(12):3401. doi: 10.3390/cells10123401.